Summerset Group Holdings (ASX:SNZ) Down 41.31% in a Year: HY26 Update in Focus

Across the broader market, the S&P/ASX 200 Health Careindex[XHJ] (INDEXASX: XHJ) stood at 31,982.20, up 0.63% (+200.50 points) as of 6 October, and is down 16% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) at the same …

Sonal Goyal | 06 October 2026

Telix Pharmaceuticals (ASX:TLX) Up Nearly 13% in Six-months: FDA Fast Track for BiPASS in Focus

Across the broader market, the S&P/ASX 200 Health Careindex[XHJ] (INDEXASX: XHJ) stood at 31,982.20, up 0.63% (+200.50 points) as of 6 October, and is down 16% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) at the same …

Sonal Goyal | 06 October 2026

4DMedical (ASX:4DX): A Year of Commercial Milestones and the FY26 Results

Across the broader market, the S&P/ASX 200 Health Careindex[XHJ] (INDEXASX: XHJ) stood at 31,982.20, up 0.63% (+200.50 points) as of 6 October, and is down 16% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) at the same …

Sonal Goyal | 06 October 2026

Ansell Limited (ASX:ANN) Up 39% in a Year: What the FY26 Result Shows

Across the broader market, the S&P/ASX 200 Health Careindex[XHJ] (INDEXASX: XHJ) stood at 31,982.20, up 0.63% (+200.50 points) as of 6 October, and is down 16% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) at the same …

Sonal Goyal | 06 October 2026

EBOS Group Limited (ASX:EBO) Down 41.05% Over 12 Months: FY26 Results in Context

Across the broader market, the S&P/ASX 200 Health Careindex[XHJ] (INDEXASX: XHJ) stood at 31,982.20, up 0.63% (+200.50 points) as of 6 October, and is down 16% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) at the same …

Sonal Goyal | 06 October 2026

Fisher & Paykel Healthcare Corporation (ASX:FPH): One-Year Share Performance and the Updated FY27 Guidance Details

Across the broader market, the S&P/ASX 200 Health Careindex[XHJ] (INDEXASX: XHJ) stood at 31,982.20, up 0.63% (+200.50 points) as of 6 October, and is down 16% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) at the same …

Sonal Goyal | 06 October 2026

Integral Diagnostics (ASX:IDX) Shares Down 21% in a Year: Reading the FY26 Numbers

Across the broader market, the S&P/ASX 200 Health Careindex[XHJ] (INDEXASX: XHJ) stood at 31,982.20, up 0.63% (+200.50 points) as of 6 October, and is down 16% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) at the same …

Sonal Goyal | 06 October 2026

Mesoblast (ASX:MSB) Down 24% in 12 Months: Ryoncil Revenue and FY26 Update in Focus

Across the broader market, the S&P/ASX 200 Health Careindex[XHJ] (INDEXASX: XHJ) stood at 31,982.20, up 0.63% (+200.50 points) as of 6 October, and is down 16% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) at the same …

Sonal Goyal | 06 October 2026

Nanosonics (ASX:NAN) Down 34% Year on Year: FY26 Results and CORIS Launch Plans in Focus

Across the broader market, the S&P/ASX 200 Health Careindex[XHJ] (INDEXASX: XHJ) stood at 31,982.20, up 0.63% (+200.50 points) as of 6 October, and is down 16% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) at the same …

Sonal Goyal | 06 October 2026

Neuren Pharmaceuticals (ASX:NEU) Down 5% Over the Year: H1 2026 Royalty and Pipeline Update in Focus

Across the broader market, the S&P/ASX 200 Health Careindex[XHJ] (INDEXASX: XHJ) stood at 31,982.20, up 0.63% (+200.50 points) as of 6 October, and is down 16% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) at the same …

Sonal Goyal | 06 October 2026

Healthcare

Summerset Group Holdings (ASX:SNZ) Down 41.31% in a Year: HY26 Update in Focus

Telix Pharmaceuticals (ASX:TLX) Up Nearly 13% in Six-months: FDA Fast Track for BiPASS in Focus

4DMedical (ASX:4DX): A Year of Commercial Milestones and the FY26 Results

Ansell Limited (ASX:ANN) Up 39% in a Year: What the FY26 Result Shows

EBOS Group Limited (ASX:EBO) Down 41.05% Over 12 Months: FY26 Results in Context

Fisher & Paykel Healthcare Corporation (ASX:FPH): One-Year Share Performance and the Updated FY27 Guidance Details

Integral Diagnostics (ASX:IDX) Shares Down 21% in a Year: Reading the FY26 Numbers

Mesoblast (ASX:MSB) Down 24% in 12 Months: Ryoncil Revenue and FY26 Update in Focus

Nanosonics (ASX:NAN) Down 34% Year on Year: FY26 Results and CORIS Launch Plans in Focus

Neuren Pharmaceuticals (ASX:NEU) Down 5% Over the Year: H1 2026 Royalty and Pipeline Update in Focus

Latest News

How Is the Global X S&P 500 High Yield Low Volatility ETF (ASX:ZYUS) Positioned at a 52-Week High?

What Minimum Volatility Exposure Offers Investors in WVOL (ASX:WVOL) at a 52-Week High?

What Does the Vanguard Global Value Equity Active ETF (ASX:VVLU) Hold as It Touches a 52-Week High?

Is the Betashares S&P 500 Equal Weight ETF (ASX:QUS) Making New Highs in November?

Can iShares Global Healthcare ETF (ASX:IXJ) Sustain Its 52-Week High Level?

How Does Betashares S&P Global High Dividend Aristocrat ETF (ASX:INCM) Reach a 52-Week High?